Top Markets
Coin of the day
Welgene Biotech Co.,Ltd. Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.

6661
Pozycja w akcjach #31671
Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis... Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis services. The company provides comprehensive support for scientific research, employing a range of advanced laboratory techniques such as genetic sequencing, microarray analysis, qPCR verification, nucleic acid extraction and quality control, LCM single cell experimentation, and intricate bioinformatics analysis. A key offering in their portfolio is Cytoscan, an array-based comparative genomic hybridization (CGH) solution. Beyond services, Welgene Biotech also supplies essential laboratory products, including various reagents, consumable items, and specialized instruments, alongside dedicated software solutions. Established in 2003, the company operates from its headquarters in Taipei City, Taiwan.
Cena akcji
$0.53422367
Kapitalizacja rynkowa
$12.45M
Zmiana (1 dzień)
0.30%
Zmiana (1 rok)
-19.98%
Kraj
TW
Handel Welgene Biotech Co.,Ltd. (6661)

Kategoria

Historia ceny akcji dla Welgene Biotech Co.,Ltd. (6661)
Najwyższa cena zamknięcia: $0.54 dnia 2026-08-01

Najniższa cena zamknięcia: $0.82 dnia 2017-10-01
Historia cen akcji firmy Welgene Biotech Co.,Ltd. od 2017 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.69%
2025 -18.28%
2024 -0.14%
2023 1.28%
2022 -17.81%
2021 -30.60%
2020 48.22%
2019 32.38%
2018 -8.61%
2017 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$586.41 20.28%
US
$202.37 -3.18%
US
$24.23 79.49%
CN
$314.26 95.01%
US
$544.68 -14.61%
US